Assessing cognitive function in patients treated with immune checkpoint inhibitors: A feasibility study.

The article presents a feasibility study which examines the cognitive function in cancer patients who received treatment of immune checkpoint inhibitors (ICIs). It defines the methodology of the study, suggesting the possibility that ICIs can induce immune-related neurological syndromes. Guidelines for further studies investigating cognitive functions in cancer patients treated with ICIs are offered.